[Giant prostate stones: case report].

Small prostate stones are often found incidentally during clinical and radiological examination. Large stones, however, also may develop, replacing completely the prostate tissue and causing various symptoms. Such a large stones are commonly formed due to chronic urine reflux. There are 20 publications in the literature devoted to the patients with giant prostate stones. Open as well as endoscopic procedures can be performed. In our clinical case both approaches were done simultaneously. Such tactic was chosen in order to carry out a single-stage intervention, immediately solving two problems, i.e., urethral stricture and a giant prostate stone.

Multiple Large Prostatic Stones Causing Chronic Pelvic Pain: A Case Report.

Apart from a few cases, prostatic stones are asymptomatic and found incidentally on routine evaluation. Current knowledge about the significance of prostatic stones in urological symptoms and chronic pelvic pain syndrome is limited. Although prostatic stones are rare, they are frequently present in patients with chronic pelvic pain syndrome and increase inflammation and duration of symptoms in these patients. We report an unusual case of a 70-year-old male who presented with lower urinary tract symptoms and chronic pelvic pain with large multiple prostatic stones and urinary bladder diverticula, which was managed endoscopically.

Clinical and Biochemical Influence of Prostatic Stones.

INTRODUCTION: The study aimed to explore clinical influence of prostatic stones on lower urinary tract symptoms (LUTS), seminal plasma cytokines, and serum biomarkers. MATERIALS AND METHODS: A total of 70 men aged ≤50 years with LUTS divided into 2 groups: group with stones (GSt) and group without prostatic stones (GNoSt). All subjects completed the International Prostate Symptom Score (IPSS) questionnaire and National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) scoring questionnaire. Pre- and post-prostate massage test and uroflowmetry were performed. The serum concentration of total prostate specific antigen (PSA), free PSA, and free/total PSA (f/t PSA) ratio, seminal concentration of cytokines interleukin (IL)-1ß, IL-6, IL-8, IL-10, IL-12p70, and tumor necrosis factor-alpha were measured. RESULTS: GSt subjects had significantly more severe symptoms based on IPSS answers (p = 0.0289). All domains in NIH-CPSI scores were significantly higher in the GSt group: pain (p = 0.001), urinary symptoms (p = 0.023), quality of life (p = 0.008), and with overall (p = 0.003). GSt subjects also had significantly lower maximum urinary flow (Qmax; p = 0.011), lower f/t PSA ratio (p = 0.048), and higher concentration of IL-1ß (p = 0.011) and IL-8 (p = 0.001). CONCLUSIONS: Prostatic stones may influence the severity of LUTS and the symptoms of chronic prostatitis. They might reduce Qmax rate and lead to reduction of the f/t PSA ratio and produce more severe inflammation causing increased seminal concentration of IL-1ß and IL-8.

Clinical study on treatment of chronic prostatitis complicated with Prostate Glioclones with urinary stone pill combined with Tylenol Hydrochloride Sustained Release Capsule / 中国生化药物杂志

Objective To study the effect of urine stone pills combined with tamsulosin hydrochloride sustained-release capsules in the treatment of chronic prostatitis with prostatic calculi. Methods 76 patients with chronic prostatitis with prostate stones who had been hospitalized were treated as 76 patients in this study. A total of 38 patients in a single group were treated with tylosine hydrochloride sustained-release capsules. 38 patients in the combined group were treated with Urethomide Pill on the basis of a single group of patients. The chronic prostatitis symptom index (NIH-CPSI) Clinical efficacy, white blood cell levels in prostatic fluid and the incidence of adverse reactions. Results The total effective rate was 94.74 % in the combined group, which was significantly lower than that in the single group (76.32 %)(P<0.05); the NIH-CPSI and prostatic fluid in the combined group were significantly lower than those in the single group(P<0.05), the incidence of adverse reactions in a single group was 7.89 %, and there was no significant difference between the combined group(5.26 %). Conclusion The treatment of chronic prostatitis with prostatic calculi is significant and feasible.

Clinical study on treatment of chronic prostatitis complicated with Prostate Glioclones with urinary stone pill combined with Tylenol Hydrochloride Sustained Release Capsule / 中国生化药物杂志

Objective To study the effect of urine stone pills combined with tamsulosin hydrochloride sustained-release capsules in the treatment of chronic prostatitis with prostatic calculi. Methods 76 patients with chronic prostatitis with prostate stones who had been hospitalized were treated as 76 patients in this study. A total of 38 patients in a single group were treated with tylosine hydrochloride sustained-release capsules. 38 patients in the combined group were treated with Urethomide Pill on the basis of a single group of patients. The chronic prostatitis symptom index (NIH-CPSI) Clinical efficacy, white blood cell levels in prostatic fluid and the incidence of adverse reactions. Results The total effective rate was 94.74 % in the combined group, which was significantly lower than that in the single group (76.32 %)(P<0.05); the NIH-CPSI and prostatic fluid in the combined group were significantly lower than those in the single group(P<0.05), the incidence of adverse reactions in a single group was 7.89 %, and there was no significant difference between the combined group(5.26 %). Conclusion The treatment of chronic prostatitis with prostatic calculi is significant and feasible.